Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.27B |
| 2 |
Zimmer Biomet
ZBH
|
+$3.42B |
| 3 |
TransUnion
TRU
|
+$1.8B |
| 4 |
Qualcomm
QCOM
|
+$587M |
| 5 |
Alibaba
BABA
|
+$434M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.06B |
| 2 |
Pfizer
PFE
|
+$895M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$631M |
| 4 |
RTX Corp
RTX
|
+$546M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$516M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.41% |
| 2 | Healthcare | 8.04% |
| 3 | Technology | 7.66% |
| 4 | Energy | 6.94% |
| 5 | Consumer Discretionary | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
PUT
iShares Russell 2000 Growth ETF
IWO
$14.3B
| $2.32M | ﹤0.01% |
+15,000
| New | +$2.3M |
|
|
KITE
3652
PUT
DELISTED
Kite Pharma, Inc.
KITE
| $2.32M | ﹤0.01% |
38,000
+31,900
| +523% | +$1.82M |
|
|
IMGN
3653
DELISTED
Immunogen Inc
IMGN
| $2.31M | ﹤0.01% |
160,826
-55,344
| -26% | -$608K |
|
3654
PUT
NRG Energy
NRG
$28.3B
| $2.31M | ﹤0.01% |
101,000
-227,300
| -69% | -$5.68M |
|
|
UPL
3655
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
| $2.31M | ﹤0.01% |
184,500
-26,489
| -13% | -$402K |
|
|
WMC
3656
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $2.31M | ﹤0.01% |
15,613
+2,582
| +20% | +$386K |
|
3657
Celestica
CLS
$38.1B
| $2.3M | ﹤0.01% |
197,678
+12,294
| +7% | +$150K |
|
3658
CALL
ResMed
RMD
$30.6B
| $2.3M | ﹤0.01% |
40,800
+38,000
| +1,357% | +$2.4M |
|
3659
PUT
Weyerhaeuser
WY
$18B
| $2.3M | ﹤0.01% |
73,000
-7,600
| -9% | -$244K |
|
3660
PUT
ASML
ASML
$626B
| $2.29M | ﹤0.01% |
22,000
-4,600
| -17% | -$492K |
|
|
CA
3661
PUT
DELISTED
CA, Inc.
CA
| $2.29M | ﹤0.01% |
78,200
+16,300
| +26% | +$506K |
|
|
NE
3662
CALL
DELISTED
Noble Corporation
NE
| $2.29M | ﹤0.01% |
148,700
-29,800
| -17% | -$492K |
|
|
XOMA
3663
DELISTED
Xoma
XOMA
| $2.29M | ﹤0.01% |
29,449
+23,792
| +421% | +$1.71M |
|
3664
CALL
Cardinal Health
CAH
$53.9B
| $2.28M | ﹤0.01% |
27,300
+7,800
| +40% | +$689K |
|
3665
Novavax
NVAX
$1.2B
| $2.28M | ﹤0.01% |
10,252
-8,446
| -45% | -$1.48M |
|
3666
Worthington Enterprises
WOR
$2.75B
| $2.28M | ﹤0.01% |
123,209
+10,165
| +9% | +$173K |
|
3667
CALL
Novartis
NVS
$297B
| $2.28M | ﹤0.01% |
25,891
+11,829
| +84% | +$1.09M |
|
3668
Harmony Gold Mining
HMY
$9.84B
| $2.28M | ﹤0.01% |
1,702,006
+742,040
| +77% | +$1.24M |
|
3669
PUT
Cleveland-Cliffs
CLF
$6.57B
| $2.28M | ﹤0.01% |
526,100
-273,700
| -34% | -$1.46M |
|
3670
Rexford Industrial Realty
REXR
$8.42B
| $2.27M | ﹤0.01% |
155,977
+35,102
| +29% | +$529K |
|
3671
iShares MSCI Philippines ETF
EPHE
$132M
| $2.27M | ﹤0.01% |
58,844
+19,362
| +49% | +$786K |
|
3672
Natural Health Trends
NHTC
$14.7M
| $2.26M | ﹤0.01% |
54,569
+36,290
| +199% | +$1.08M |
|
3673
First Bancorp
FBP
$4.42B
| $2.26M | ﹤0.01% |
468,779
+316,988
| +209% | +$2M |
|
3674
First Financial Bancorp
FFBC
$3.55B
| $2.26M | ﹤0.01% |
125,761
-27,486
| -18% | -$483K |
|
3675
CALL
Trip.com Group
TCOM
$29.6B
| $2.25M | ﹤0.01% |
62,000
-20,800
| -25% | -$726K |
|
Similar funds
Goldman Sachs's Q2 2015 Portfolio in Review
As of Q2 2015, Goldman Sachs held 7,731 positions worth $323B, up 3.7% from $311B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Goldman Sachs deployed $13.1B of net new capital in Q2 2015, opening 673 new positions and adding to 3,224 existing holdings. Its largest new stake was TransUnion: 72,355,340 shares worth $1.82B.
By sector, the portfolio is most concentrated in Financials at 8.4% of assets, up from 8% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Gilead Sciences, an estimated $1.06B trimmed.
- Goldman Sachs's largest Q2 2015 buy was TransUnion: 72,355,340 shares worth $1.82B.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $4.27B increase.
- Goldman Sachs's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $1.06B.
- Goldman Sachs fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $386M.
- Goldman Sachs's ten largest holdings make up 14% of its $323B portfolio in Q2 2015.
- Goldman Sachs opened 673 new positions and closed 497 in Q2 2015.
- Goldman Sachs's portfolio value rose 3.7% quarter-over-quarter to $323B.
Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.